Evidence map›Paper›PMID 28497379›Full record

ReviewDer Internist2017

[Choosing wisely recommendations in cardiology].

K Werdan, S Baldus, N Frey, U Nixdorff, K-H Kuck, H Katus

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Internist, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

K WerdanDeutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Grafenberger Allee 100, 40237, Düsseldorf, Deutschland. karl.werdan@medizin.uni-halle.de.
S BaldusDeutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Grafenberger Allee 100, 40237, Düsseldorf, Deutschland.
N FreyDeutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Grafenberger Allee 100, 40237, Düsseldorf, Deutschland.
U NixdorffDeutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Grafenberger Allee 100, 40237, Düsseldorf, Deutschland.
K-H KuckDeutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Grafenberger Allee 100, 40237, Düsseldorf, Deutschland.
H KatusDeutsche Gesellschaft für Kardiologie - Herz- und Kreislaufforschung, Grafenberger Allee 100, 40237, Düsseldorf, Deutschland.
German Cardiac Society · DEAsklepios Klinik St. Georg · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article describes controversially discussed Choosing wisely recommendations presented by the German Cardiac Society: anticoagulation therapy in patients with atrial fibrillation and "only" moderate stroke risk, on the one hand, and goal-directed low-density lipoprotein (LDL) cholesterol-lowering, on the other. Presuming an adequate regime, patients with atrial fibrillation and only moderate risk of stroke (CHA

Indexed as

Age FactorsAnticoagulantsAtrial FibrillationCardiologyCholesterol, LDLFemaleGermanyHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMalePractice Guidelines as TopicSocieties, MedicalStrokeAnticoagulantsCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsAnticoagulantsAtrial fibrillationCholesterol, LDLCoronary diseaseHydroxymethylglutaryl-CoA reductase inhibitors

Identifiers

PMID28497379
OpenAlexW2613320940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.